Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LGMD2B”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Ended earlyNCT05906251
What this trial is testing

A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related)

Who this might be right for
Limb Girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 2
Not applicableEnrolling By InvitationNCT04989751
What this trial is testing

Phenotype-Genotype Analysis of LGMD Patients in China

Who this might be right for
LGMDLGMDR2LGMDR1
Huashan Hospital 450
Not applicableStudy completedNCT00893334
What this trial is testing

Evaluation of Limb-Girdle Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyLimb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)+1 more
Cooperative International Neuromuscular Research Group 60
Not applicableEnrolling By InvitationNCT04824040
What this trial is testing

Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF

Who this might be right for
DysferlinopathyMiyoshi MyopathyLGMDR2+1 more
Artgen Biotech 100
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Early research (Phase 1)Ended earlyNCT01863004
What this trial is testing

Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin

Who this might be right for
Dysferlinopathy
University Hospital, Basel, Switzerland 3
Large-scale testing (Phase 3)Study completedNCT00527228
What this trial is testing

Deflazacort in Dysferlinopathies

Who this might be right for
LGMD2BMiyoshi MyopathyDysferlinopathy
Ludwig-Maximilians - University of Munich 25
Not applicableUnknownNCT01676077
What this trial is testing

Clinical Outcome Study for Dysferlinopathy

Who this might be right for
DysferlinopathyLGMD2B Now Classified as LGMDR2Miyoshi Myopathy
Newcastle-upon-Tyne Hospitals NHS Trust 200
Early research (Phase 1)Study completedNCT02710500
What this trial is testing

RAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

Who this might be right for
Dysferlinopathy
Sarepta Therapeutics, Inc. 2
Not applicableStudy completedNCT06507215
What this trial is testing

Dysferlinopathy Protein in Peripheral Blood Monocytes.

Who this might be right for
Muscular DystrophiesLimb-Girdle Muscular Dystrophy Type 2BMiyoshi Myopathy+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 149